Skip to main content

Want a detailed portfolio tracker?

NeOnc Technologies (NTHI) P/E (2025 - 2026)

NeOnc Technologies (NTHI) P/E from Mar 26, 2025 to Jul 21, 2026. The TTM NeOnc Technologies (NTHI) P/E is -1.87. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of NeOnc Technologies (NTHI)

YearP/EChange
2026-1.87-28.86%
2025-2.63N/A

Comparison NeOnc Technologies (NTHI) P/E with competitors

NeOnc Technologies (NTHI) P/E is -1.87.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.23%
ENLVEnlivex Ltd0.07-104.00%
FGENFibroGen Inc0.24-112.84%
CHRSCoherus Biosciences Inc0.85-145.38%
FBIOFortress Biotech Inc0.95-150.75%
ORMPOramed Pharmaceuticals Inc1.50-180.38%
AGENAgenus Inc3.01-260.94%
INVAInnoviva Inc3.15-268.66%
VXRTVaxart Inc3.55-289.82%
CRMDCorMedix Inc3.63-294.03%
CVACCureVac N.V.4.45-337.74%
GLPGGalapagos NV4.86-359.83%
SRPTSarepta Therapeutics Inc4.88-361.07%
ABEOAbeona Therapeutics Inc5.39-388.10%
ABUSArbutus Biopharma Corp5.60-399.23%
ZVRAZevra Therapeutics Inc5.89-414.82%
SPROSpero Therapeutics Inc6.23-433.07%
CGENCompugen Ltd6.31-437.64%
RIGLRigel Pharmaceuticals6.87-467.49%
SLXNSilexion Therapeutics Corp7.30-490.16%
OMEROmeros Corporation9.26-595.12%
AUPHAurinia Pharmaceuticals Inc9.58-612.56%
PLXProtalix BioTherapeutics Inc10.89-682.40%
ACADAcadia Pharmaceuticals Inc11.73-727.19%
TBPHTheravance Biopharma Inc12.26-755.73%
ADMAAdma Biologics Inc12.42-764.07%
HRMYHarmony Biosciences Holdings Inc13.82-839.05%
SABSSAB Biotherapeutics Inc14.14-855.94%
NAGENiagen Bioscience Inc14.82-892.41%
INCYIncyte Corp15.82-946.12%
REGNRegeneron Pharmaceuticals Inc15.86-947.95%
PBYIPuma Biotechnology Inc17.32-1025.97%
CPRXCatalyst Pharmaceuticals Inc17.44-1032.58%
EXELExelixis Inc17.54-1037.86%
TGTXTG Therapeutics Inc18.97-1114.23%
MDXGMimedx Group Inc20.55-1199.06%
XOMAXOMA Royalty Corp22.87-1323.28%
ARGXArgen X SE24.30-1399.39%
CTMXCytomX Therapeutics Inc24.82-1427.36%
XOMAOXOMA Royalty Corp25.34-1455.37%
HALOHalozyme Therapeutics Inc25.62-1470.29%
XOMAPXOMA Royalty Corp25.67-1472.77%
VRTXVertex Pharmaceuticals Inc27.99-1597.08%
RPRXRoyalty Pharma plc - Class A28.69-1634.13%
SLNOSoleno Therapeutics Inc29.02-1651.66%
ASNDAscendis Pharma A/S30.09-1708.89%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2127.43%
APLSApellis Pharmaceuticals Inc39.02-2186.75%
BMRNBiomarin Pharmaceutical Inc42.21-2357.37%
KRYSKrystal Biotech Inc45.34-2524.84%
ONCBeiGene Ltd69.54-3818.83%
PHARPharming Group N.V.75.03-4112.16%
TECHBio-Techne Corp101.96-5552.46%
VCELVericel Corp109.92-5978.30%
ALNYAlnylam Pharmaceuticals Inc117.96-6408.45%
GMABGenmab140.29-7602.37%
TLXTelix Pharmaceuticals Ltd162.15-8771.49%
CORTCorcept Therapeutics Inc212.86-11483.04%